Tarsus Pharmaceuticals, Inc.
TARS
Revenue
151.67M
▲32.97M▲27.78%
3 Months ChangeAssets
562.16M
▲27.60M▲5.16%
3 Months ChangeLiabilities
218.73M
▲19.25M▲9.65%
3 Months ChangeFree Cash Flow
-21.24M
▲16.72M▲44.05%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-23
Form 8-K
ID: 0001819790-26-000017
2026-02-18
Form 8-K
ID: 0001819790-26-000005
2026-01-12
Form 8-K
ID: 0001819790-26-000002
2025-11-04
Form 10-Q
ID: 0001819790-25-000121
2025-11-04
Form 8-K
ID: 0001819790-25-000120
2025-08-06
Form 10-Q
ID: 0001819790-25-000108
2025-08-06
Form 8-K
ID: 0001819790-25-000107
2025-06-18
Form 8-K
ID: 0001819790-25-000100
2025-05-01
Form 10-Q
ID: 0001819790-25-000078
2025-05-01
Form 8-K
ID: 0001819790-25-000077